Hello, everyone, and how are you this morning? We are doing just fine, thank you, despite the gloomy skies hovering over the Pharmalot campus. After all, as the Morning Mayor used to say: “Every day should be unwrapped like a brand new gift.” So while you tug on the ribbon, we will brew more cups of stimulation — chocolate cherry decadence has our attention today — and forage for interesting items. Speaking of which, here are your tidbits. Hope your day is splendid and, as always, do keep in touch.

The Senate Health, Education, Labor, and Pensions Committee holds a hearing today at 10 a.m. EST to discuss prescription drug pricing. The gathering will focus on a recent report from The National Academies of Sciences, Engineering, and Medicine, which offered some provocative suggestions, although this will be the third hearing on drug prices that the Senate health committee has held this year. You can watch here.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy